Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Others
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
TargetMol | Tags By Application
  • ELISA
    (1)
  • FCM
    (1)
  • Functional assay
    (1)
Filter
Search Result
Results for "

ociperlimab

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    1
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
Ociperlimab
WCD-118, WCD118, BGB-A1217, BGBA1217
T783242342597-93-5
Ociperlimab (BGB-A1217) is a novel humanized monoclonal antibody targeting TIGIT that exhibits antitumor activity. Ociperlimab blocks the TIGIT/PVR signaling pathway with high affinity and, through its Fc effector functions, synergistically enhances antitumor immune responses via multiple mechanisms. Ociperlimab is indicated for the treatment of advanced solid tumors.
  • $182
In Stock
Size
QTY